Fierce Healthcare13h
Trump's CMS signals flexibility on Medicare drug price negotiation, sparking new questions for RFK Jr.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
RFK Jr. grilled on Medicare: What is Medicare Part A, Medicare Part B and Medicaid? What are they?
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Medicare Change Backed by 20,000 People in New Letters
New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
McKnight's Long-Term Care News3h
MA plans’ use of prior authorizations climbs again, despite heightened pressure to limit tactic
MA plans required prior authorizations about 125 times more often than regular Medicare in 2023, demonstrating the barriers patients face in accessing care.
JD Supra1d
Medicare’s 60-Day Rule
The Centers for Medicare & Medicaid Services (CMS) finalized significant updates to the Medicare 60-Day Rule, which governs ...
RFK Jr. Confused Medicare and Medicaid: Here's the Difference
The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We ...
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Healio1d
‘We applaud CMS’: Two more rheumatology drugs bound for Medicare price negotiation
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Modern Healthcare6d
CMS drops appeal in UnitedHealth Medicare Advantage ratings case
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
CMS aiming for more transparency in drug pricing negotiations
CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...
JD Supra1d
Two Major Updates to Pennsylvania Medicare Set-Aside Rules
The Centers for Medicare & Medicaid Services (CMS) recently announced two significant updates to Workers’ Compensation ...
Medscape20h
Unsustainable Biosimilar Market Leaves Practices, Patients at a Loss
The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.